Zheng Wang

This inventor holds 46 USPTO granted patents and 35 published patent applications and 20 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Chinese Academy of Sciences, Shanghai Haiyan Pharmaceutical Technology Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zheng Wang. Retrieved from https://idiyas.com/inventor/zheng-wang-qny5gbtw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 46 (Patent Applications = 35)

% Patents Active = 89.1

EPO Patents = 20 (Patent Applications = 45)

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 54(Granted Patents)

Company Filing History:

5 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

5 out of 3,364

Chinese Academy of Sciences

patents

5 out of 20

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

patents

4. 5 out of 26

Yangtze River Pharmaceutical Group Co., Ltd.

patents

5. 4 out of 605

Delta Electronics (Shanghai) Co., Ltd

patents

6. 3 out of 10

Shandong Danhong Pharmaceutical Co., Ltd.

patents

7. 2 out of 392

Business Objects Software Limited

patents

8. 2 out of 5

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

patents

9. 2 out of 4

Humanwell Healthcare (Group) Co., Ltd.

patents

10. 2 out of 5

Shanghai Dalong Technology Co., Ltd.

Fujian Akeylink Biotechnology Co., Ltd.

General Electric Technology Gmbh

patents

15. 1 out of 13

Guangdong Raynovent Biotech Co., Ltd.

patents

16. 1 out of 3

Guangzhou Joyo Pharmatech Co., Ltd

patents

17. 1 out of 4

Guangzhou Joyo Pharmatech Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory

patents

20. 1 out of 374

On-Bright Electronics (Shanghai) Co., Ltd.

patents

21. 1 out of 11

Qilu Pharmaceutical Co., Ltd.

Shanghai Avic Opto Electronics Co., Ltd.

patents

24. 1 out of 1

Shanghai Bao Pharmaceuticals Co., Ltd.

patent

25. 1 out of 2

Shanghai Chemrun Co. Ltd.

patents

26. 1 out of 1

Shanghai Greencarbon Hi-Tech Co., Ltd.

patent

27. 1 out of 158

Shpp Global Technologies B.v.

patents

28. 1 out of 680

Tianma Micro-Electronics Co., Ltd.

patents

29. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Orexin Receptor Antagonist

Sodium Ion Channel Inhibitor

Chiral Spirobiindane

Crystal Form

Thermoplastic Composition

Power Conversion System

User Intention Design

Multiport Chargers

High Branched Alkane

Skin Care Composition

Virtual Input Device

Catalytic System

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734177 - Macrocyclic derivative and use thereof (2026-09-15),

2. 12577468 - Thermoplastic compositions and uses thereof (2026-03-17),

3. 12555285 - User intention oriented responsive design for applications running on multiple devices (2026-02-17),

4. 12514346 - Gem applier and method (2026-01-06),

5. 12469601 - Method and system for individualized prediction of mental illness on basis of brain function map monkey-human cross-species migration (2025-11-11),

6. 12458647 - Macrocyclic derivative and use thereof (2025-11-04),

7. 12438381 - Systems and methods for power sharing related to multiport chargers (2025-10-07),

8. 12319942 - Use of mutant of immunoglobulin degrading enzyme IdeE (2025-06-03),

9. D1059400 - Display screen or portion thereof with animated graphical user interface (2025-01-28),

10. 12116367 - Ring-modified proline short peptide compound and use thereof (2024-10-15),

11. 11907741 - Virtual input device-based method and system for remotely controlling PC (2024-02-20),

12. 11325875 - Compound having chiral spirobiindane skeleton and preparation method therefor (2022-05-10),

13. 11124506 - Salts and crystal forms of diaza-benzofluoranthrene compounds (2021-09-21),

14. 10947245 - Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity (2021-03-16),

15. 10947202 - Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereof (2021-03-16),

Title: Innovator Profile: Zheng Wang

Introduction: Zheng Wang is a prominent inventor based in Shanghai, China, known for his significant contributions to various fields through his innovative work. With an impressive portfolio of 38 patents, he continues to make a mark in the pharmaceutical and technology industries.

Latest Patents: Zheng Wang's recent patents highlight his versatility and creativity. His notable patents include a "Display screen or portion thereof with animated graphical user interface," which showcases advancements in user interface design. Additionally, he has developed a "Ring-modified proline short peptide compound and use thereof," focusing on a compound represented by a specific formula, aimed at pharmaceutical applications.

Career Highlights: Throughout his career, Zheng has worked with reputable companies, notably Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical sector.

Collaborations: Zheng Wang has collaborated with talented individuals such as Weidong Li and Haiying He. These professional partnerships have significantly enhanced his ability to innovate and develop impactful patents, demonstrating the importance of teamwork in the pursuit of technological advancement.

Conclusion: Zheng Wang stands out as an influential inventor whose work continues to shape the landscape of technology and pharmaceuticals. With a robust portfolio of patents and a commitment to innovation, he is poised to make further contributions that will benefit various industries.

Profile summary based on public USPTO records.